NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
- Type
- Retraction
- Notice date
- 7/12/2023 0:00
- Journal
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9876715
- Original paper DOI
- 10.1155/2022/1890823
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Peer Review
- Informed/Patient Consent - None/Withdrawn
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions